Roivant (ROIV) President Eric Venker Withholds 13,909 Shares for Taxes

What Happened
Eric Venker, President of Roivant Sciences and CEO of Immunovant, had 13,909 shares disposed (net-settlement of RSUs) on Aug 20, 2026 at $36.84 per share, for a total value of $512,408. This was a tax-withholding/net settlement related to vested RSUs, not an open-market sale.

Key Details

• Transaction date: 2026-08-20; Filing date: 2026-08-24 (filed on time)
• Price per share: $36.84; Shares involved: 13,909; Total value: $512,408
• Transaction code: F (tax withholding / net settlement)
• Footnote: F1 — Issuer net-settled RSUs previously granted to satisfy tax withholding obligations on vesting
• Shares owned after transaction: Not specified in this Form 4

Context
Net-settlement of RSUs is a routine administrative action where the company withholds/retains shares to cover tax obligations when awards vest. This is generally not a directional trading signal like an open-market sale or purchase.